ArticleLupus science & medicine2026

Peripheral blood CD19+B cell proportion at baseline predicts early complete response to belimumab treatment in patients with refractory lupus nephritis.

Xinxin Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.